Ault Milton C III's Form 4 filing
Alzamend Neuro, Inc. (ALZN) · filed Sep 19, 2025
- Accession no.
- 0001214659-25-013976
- Filed
- Sep 19, 2025
- Trade date
- Sep 17-18, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $56.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ault Milton C IIICIK 0001212502 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2025 | Common Stock | CConversionAcquired | +100,000 | $2.32 | +$232,000 | 108,260 | Indirect | |
| Sep 17, 2025 | Common Stock | SSaleDisposed | −2,121 | $2.45 | −$5,196.45 | 106,139 | Indirect | |
| Sep 18, 2025 | Common Stock | SSaleDisposed | −20,870 | $2.47 | −$51,548.9 | 85,269 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2025 | Common Stock | CConversionDisposed | −100,000 | $1,000.00 | −$232,000 | 1,303.24 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.